Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
about
Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunityRedefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophyAPECED mutations in the autoimmune regulator (AIRE) geneAutoimmune polyendocrinopathy syndrome type 1: treat with kid gloves.Addison's Disease Revisited in Poland: Year 2008 versus Year 1990.Autoimmune regulator: from loss of function to autoimmunity.Autoantibodies against Cytochrome P450 Side-Chain Cleavage Enzyme in Dogs (Canis lupus familiaris) Affected with Hypoadrenocorticism (Addison's Disease).Pure red cell aplasia associated with type I autoimmune polyglandular syndrome-successful response to treatment with mycophenolate mofetil: case report and review of literature.Clinical phenotypes of autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy seen in the Northern Ireland paediatric population over the last 30 yearsGenes mediating environment interactions in type 1 diabetes.A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1.Endocrinology and the skin.Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome.Perspectives in Pediatric Pathology, Chapter 22. Testicular Involvement in Systemic Diseases.Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.Altered Immune Activation and IL-23 Signaling in Response to Candida albicans in Autoimmune Polyendocrine Syndrome Type 1Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.Subjective health status in Norwegian patients with Addison's disease.Novel compound heterozygous AIRE mutations in a Japanese patient with APECED.Oral microbiota in autoimmune polyendocrine syndrome type 1.Clinical, Genetic and Immunological Characteristics of Paediatric Autoimmune Polyglandular Syndrome Type 1 Patients in Slovenia.Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
P2860
Q24684338-1AC234A8-06CC-454C-BC6C-7989CF434BD0Q27333247-198B7D28-5BEB-4CDA-B18B-90B2F6D825ACQ28214535-4292CC29-9E3B-454A-8A39-92279CDA8F30Q34229303-1B4E188A-64BC-435F-AC11-DC3EA232E251Q34423905-122B882E-0C5B-4CA8-A031-87CED629B919Q35069571-B6F05935-DC9C-4D0B-9015-BF575110ECE8Q35855743-D3F1E215-20D4-4675-9B68-F0DAAADE7220Q35954307-D4268ACC-B7CB-40C0-B44E-6F038AA1D606Q36785657-FACA98E4-5167-4BD7-8A72-9E19A7DB539FQ36816687-5C593FC8-CE8A-4F26-932F-BD30DD98D5A5Q37147503-513700EE-D136-4290-BF96-BD30CA428D0CQ37280054-2EE8D748-3711-42C0-BAEB-A7C1188F77E8Q37974985-6230576E-DA6D-4565-913B-33F8F2641A6DQ38261745-C7F8E8CD-0843-49A8-B1EB-87D74B7A3F46Q38542575-31D9738C-C28B-4708-A9A2-33D9A584BC10Q41619568-8B9BE10F-4C73-4D38-A2CF-A99C557294F0Q42229891-01BE9A0D-F535-4ECB-AD0C-3FF964D523B3Q44006170-4E65E166-A1B7-4BF3-A68E-60C3910B6EE2Q44990558-302C4182-2687-4E94-AEF9-67249507B35CQ50333123-15C30926-ED6B-4B21-AB42-71B22864517FQ54868938-649CFE02-7538-47D4-A142-48976F426CAEQ55041978-B3BC4DBC-F955-4E7C-AECE-6D6AA696B765
P2860
Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
@en
type
label
Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
@en
prefLabel
Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
@en
P2093
P2860
P1476
Autoimmune polyendocrine syndrome type 1 (APS I) in Norway.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2265.2001.01201.X
P577
2001-02-01T00:00:00Z